Federal Opioid Response Fairness Act of 2017

Bill: 115-hr-4190
Sponsor: full_name: Rep. Kuster, Ann M. [D-NH-2]
Introduced: 2017-10-31
Policy area: Health
Subjects: Child health

Drug trafficking and controlled substances

Drug, alcohol, tobacco use

Health programs administration and funding

Health promotion and preventive care
Latest action: action_date: 2017-11-03
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2017-10-31
action_desc: Introduced in House
text: <p><b>Federal Opioid Response Fairness Act of 2017</b></p> <p>This bill amends the 21st Century Cures Act to alter the Substance Abuse and Mental Health Services Administration opioid grant program for states. Specifically, the bill alters the criteria for the award of grants by prioritizing states with an increasingly high rate of opioid-use disorders and a comparatively high prevalence of opioid-use disorder adverse health effects and per capita overdose mortality rates. </p>

tv_txt: I 115th CONGRESS 1st Session H. R. 4190 IN THE HOUSE OF REPRESENTATIVES October 31, 2017 Ms. Kuster of New Hampshire (for herself and Mr. Jenkins of West Virginia ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the 21st Century Cures Act to ensure the equitable distribution of resources to address the opioid epidemic, and for other purposes.

1. Short title This Act may be cited as the Federal Opioid Response Fairness Act of 2017 . 2. Equitable distribution of resources to address the opioid epidemic (a) In general The second sentence in paragraph (1) of section 1003(c) of the 21st Century Cures Act ( Public Law 114–255 ; 42 U.S.C. 290ee–3 note) is amended by striking States with an incidence or prevalence of opioid use disorders that is substantially higher relative to other States. and inserting States— (A) with an incidence or prevalence of opioid use disorders and associated adverse health effects, including neonatal abstinence syndrome, that are substantially higher relative to other States; (B) in which the incidence rate of opioid use disorders, or the opioid-related drug overdose mortality rate, is substantially higher than what such rate was during the year immediately preceding the year in which such grants are awarded; and (C) with a per capita prescription opioid, heroin, or synthetic opioid overdose mortality rate that is substantially higher relative to other States. . (b) Technical amendment The first sentence in paragraph (1) of section 1003(c) of the 21st Century Cures Act ( Public Law 114–255 ; 42 U.S.C. 290ee–3 note) is amended by striking in accordance with subparagraph (B) and inserting in accordance with paragraph (2) .